AI Summary
✦ ClarthaValuation Metrics
Trading 10.3% above historical median. Valuation is declining — currently in the overvalued zone (z-score: +0.87). Confidence: 89%.
Live forward EPS implies next-12-month EPS of ₹55.88. Applying the stock's normalized valuation corridor produces a fair range of ₹2,359.25 to ₹2,740.36, with base value near ₹2,528.57 (+92.3% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹55.88
Forward P/E
23.5x
Base Fair Value
₹2,528.57
Fair Range
₹2,359.25 - ₹2,740.36
Upside To Base
+92.3%
Estimate Source
Live forward EPS
Growth Estimate
+37.3%
5Y Average
45.60
Current
49.91
Overvalued
49.04
Undervalued
42.22
5Y Average
0.73
Current
0.80
Overvalued
0.84
Undervalued
0.62
5Y Average
2.96
Current
3.39
Overvalued
3.41
Undervalued
2.52
Peers & Comparison
Sector: Health Care · Theme: Pharmaceuticals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
AKUMS DRUGS AND PHARMA L AKUMSPharmaceuticals | +9.6% | 5.9% | 43.6x Undervalued | -35% vs avg | +51.8% |
BLUE JET HEALTHCARE LTD BLUEJETPharmaceuticals | -17.4% | 26.5% | 43.6x Undervalued | -35% vs avg | -25.8% |
CONCORD BIOTECH LIMITED CONCORDBIOPharmaceuticals | +26.2% | 24.8% | 47.3x Undervalued | -29% vs avg | -17.2% |
CAPLIN POINT LAB LTD. CAPLIPOINTPharmaceuticals | +19.0% | 29.3% | 31.2x Undervalued | -53% vs avg | +22.8% |
ASTRAZENECA PHARMA IND LT ASTRAZENPharmaceuticals | +20.4% | 8.2% | 106.8x Premium | +60% vs avg | -6.7% |
ALIVUS LIFE SCIENCES LTD ALIVUSPharmaceuticals | +6.4% | 23.3% | 27.5x Undervalued | -59% vs avg | +43.2% |
COHANCE LIFESCIENCES LTD COHANCEPharmaceuticals | -23.1% | 5.0% | 167.5x Premium | +151% vs avg | -52.5% |
ENTERO HEALTHCARE SOLU L trades at a discount (54.0x vs peer avg 66.8x), suggesting potential undervaluation relative to the Pharmaceuticals cohort. Peers include AKUMS DRUGS AND PHARMA L, BLUE JET HEALTHCARE LTD, CONCORD BIOTECH LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.